Securisyn Medical awarded $250,000 Early Stage Capital and Retention Grant

The Colorado Office of Economic Development and International Trade (OEDIT) has awarded Securisyn Medical a $250,000 Early Stage Capital and Retention Grant to accelerate required FDA 510(k) testing and post-clearance clinical trials for the Company’s patented airway stabilization system, SolidAIRity™.